Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Xeris Pharmaceuticals Inc (XERS)  
$1.75 0.05 (2.94%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 135,531,000
Market Cap: 237.18(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.47 - $3.22
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Xeris Biopharma Holdings is a pharmaceutical company. Co.'s primary focus is on therapies for patient populations in endocrinology, neurology, and gastroenterology. Co.'s products include: Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages two years and older; Keveyis, the U.S. Food and Drug Administration approved therapy for hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev (levoketoconazole), a cortisol synthesis inhibitor used for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 83
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Prestrelski Steven Chief Scientific Officer   •       –      –    2021-10-05 4 D $0.00 $0 D/D (494,780) 0     -
   Pieper Steven Chief Financial Officer   •       –      –    2021-10-05 4 D $0.00 $0 D/D (158,108) 0     -
   Hecht Beth See Remarks   •       –      –    2021-10-05 4 D $0.00 $0 D/D (206,366) 0     -
   Edick Paul R Chief Executive Officer   •       •      –    2021-10-05 4 D $0.00 $0 I/I (13,430) 0     -
   Edick Paul R Chief Executive Officer   •       •      –    2021-10-05 4 D $0.00 $0 D/D (608,064) 0     -
   Shannon John Patrick Jr See Remarks   •       –      –    2021-10-05 4 D $0.00 $0 D/D (263,829) 0     -
   Johnson Kenneth Erland See Remarks   •       –      –    2021-10-05 4 D $0.00 $0 D/D (89,583) 0     -
   Schmid John P. Director   –       •      –    2021-10-05 4 D $0.00 $0 D/D (5,659) 0     -
   Pieper Steven See Remarks   •       –      –    2021-07-28 4 A $0.00 $0 D/D 100,000 158,858     -
   Prestrelski Steven Chief Scientific Officer   •       –      –    2021-04-12 4 AS $4.07 $40,725 D/D (10,000) 496,824 -43%     
   Prestrelski Steven Chief Scientific Officer   •       –      –    2021-01-29 4 A $0.00 $0 D/D 100,000 506,824     -
   Johnson Kenneth Erland See Remarks   •       –      –    2021-01-29 4 A $0.00 $0 D/D 65,000 91,890     -
   Shannon John Patrick Jr See Remarks   •       –      –    2021-01-29 4 A $0.00 $0 D/D 150,000 271,224     -
   Edick Paul R See Remarks   •       •      –    2021-01-29 4 A $0.00 $0 D/D 225,000 636,134     -
   Hecht Beth See Remarks   •       –      –    2021-01-29 4 A $0.00 $0 D/D 150,000 210,814     -
   Deutsch Barry M. See Remarks   •       –      –    2021-01-29 4 A $0.00 $0 D/D 115,000 208,090     -
   Prestrelski Steven Chief Scientific Officer   •       –      –    2021-01-13 4 AS $6.01 $60,058 D/D (10,000) 406,824 -43%     
   Prestrelski Steven Chief Scientific Officer   •       –      –    2021-01-11 4 AS $5.72 $57,244 D/D (10,000) 416,824 -39%     
   Prestrelski Steven Chief Scientific Officer   •       –      –    2020-12-16 4 GD $0.00 $0 D/D 10,000 426,824     -
   Edick Paul R See Remarks   •       •      –    2020-12-09 4 B $4.06 $40,551 D/D 10,000 411,134 2.81 -4%     
   Hecht Beth See Remarks   •       –      –    2020-06-30 4 A $2.26 $8,432 D/D 3,731 60,814     -
   Shannon John Patrick Jr See Remarks   •       –      –    2020-06-30 4 A $2.26 $8,432 D/D 3,731 121,224     -
   Johnson Kenneth Erland See Remarks   •       –      –    2020-06-30 4 A $2.26 $1,752 D/D 775 26,890     -
   Deutsch Barry M. See Remarks   •       –      –    2020-06-30 4 A $2.26 $8,432 D/D 3,731 93,090     -
   Shannon John Patrick Jr See Remarks   •       –      –    2020-05-13 4 B $3.55 $77,994 D/D 22,000 117,493 2.74 65%     
  83 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us